Xbrane today announced a termination of partnership with Bausch and Lomb for the US market. The share price went down by more than 25% on the news. The company had today a very positive call that pushed the share price up. CEO confirmed that Xbrane would find a new US partner before the US launchContinue reading “Xbrane – Down 20% Today – Why we Bought”
Biovica – One of the Most Interesting Scandi Pharma – Notes from the Call with Mgmt
Biovica is one of the most interesting companies in Scandinavian pharma sector. It has the first ever FDA approved biomarker test for breast cancer. According to Bloomberg (link in SA), Biomarker testing will change the way cancer is treated. Biovica should be one of the main beneficiaries. Pareto estimates Biovica sales to exceed USD100 millionContinue reading “Biovica – One of the Most Interesting Scandi Pharma – Notes from the Call with Mgmt”
Los Andes Copper – Strategic Partnership or Sale to Global Major in Motion
Chile accounts for a quarter of the world’s mined copper and has the most reserves. Los Andes Copper is located in Chile’s Central Copper Belt between three large copper mining operations by global majors. Last week Los Andes announced they are “considering options to finance development… including potential sale”. Historically such processes lead to significantContinue reading “Los Andes Copper – Strategic Partnership or Sale to Global Major in Motion”
Biovica’s Q4 Report: Progressing Towards Strong Sales and Financing
I asked Chat GPT to summarize Biovica Investment Thesis. The result is below: Introduction:Biovica, a leading diagnostic solutions company, recently released its Q4 2022/23 interim report, showcasing significant advancements in their US launch. The report highlights the company’s achievements, future sales projections, financing plans, and collaborations with healthcare providers and pharmaceutical companies. This blog postContinue reading “Biovica’s Q4 Report: Progressing Towards Strong Sales and Financing”
Africa Energy: Good News From Eskom
South Africa´s New24.com published yesterday an article that Eskom is asking for bids to convert its Mossel bay power station from diesel to gas. Block 11B/12B is the only potential gas supplier nearby. Eskom would not be planing a diesel to gas conversion if it did not have a certainty of gas supplies. It indicatesContinue reading “Africa Energy: Good News From Eskom”
Vicore Raised 500 mil SEK with Specialist Investors – Stock up 15%
Vicore share issue was in big demand. Most investors got zero allocations. The stock was allocated mainly to major specialist pharma investors from the USD and Europe and selected existing investors. The issue was placed close to market price. Strong rubber stamp on the investment case. Vicore +15% today. We are bullish Vicore. Our familyContinue reading “Vicore Raised 500 mil SEK with Specialist Investors – Stock up 15%”
Stanley Druckenmiller interview
Fascinating interview with Stanley Druckenmiller for Bloomberg – he talks on AI – it may be as transformative as internet was. Stanley is concerned about US debt and bearish on China. He talks about his recession concerns. Must watch for any investor. ONly 30 minutes or so. Disclosure: The goal of the blog is toContinue reading “Stanley Druckenmiller interview”
Call with Africa Energy
We had a call with Africa Energy yesterday. Below are the notes from the call. I think the most important take out for us was that the Production Rights Licence should be issued by South African government by 1Q24. By that time the off-take agreement should be in place. Two major catalysts in the nextContinue reading “Call with Africa Energy”
Vicore – First Drug that Cures IPF – Trading at 1/7 of US listed but worse Pliant
Vicore is trading at 1/7 of its peer Pliant, that shows much worse results than Vicore. On Sunday Vicore published their latest IPF readouts in the most important IPF conference in Washington DC. The data reaffirmed “unprecedented regenerative profile of Vicore´s drug in IPF” On Sunday Vicore Pharma has announced additional data from the AIRContinue reading “Vicore – First Drug that Cures IPF – Trading at 1/7 of US listed but worse Pliant”
Scandinavian Opportunities for This Week
Summary of the Scandinavian opportunities we saw in the market last week. Short Rec Silicon – Capital Raise this week? All analysts indicate that Rec Silicon needs to raise capital. Usually, companies do investor roadshows before they raise capital. Rec Silicon did their roadshow from 11/5 till 15/5. Last week was a short holiday weekContinue reading “Scandinavian Opportunities for This Week”